Severe flu risk as immune cells swap with age

Severe flu risk as immune cells swap with age
AM and Mo-derived cells in influenza-infected mice. FeMo-reconstituted Csf2ra-/- and WT mice were infected with IAV (20 pfu PR8) as depicted in Fig. 2A. Representative gates and dot plots of BAL AM and BMo-Mac are shown on d10 and d21 p.i. Data are representative of at least 3 independent experiments with n=3 mice per group at each timepoint. Credit: Science Immunology (2022). DOI: 10.1126/sciimmunol.abj5761

Lung infections with the influenza virus or a coronavirus more frequently result in severe disease progression in older people. This is due to an excessive inflammatory reaction that causes damage to the lung tissue. The exact causes are not yet clear. Macrophages, also known as the immune system's scavenger cells, play a role. They release pro-inflammatory messengers, which then trigger a severe immune response.

A team of researchers lead by Manfred Kopf, an and Professor of Molecular Biomedicine at ETH Zurich, has shown that in mice originally resident scavenger cells in the lung—called embryonic alveolar —rapidly die when the animals are infected with the influenza virus and are replaced after a few days by macrophages from the . The more severe the infection, the more embryonic alveolar macrophages die. The ETH immunologists recently reported their findings in the journal Science Immunology.

Differences in function and disease progression

Macrophages have several functions, including first line of defense against pathogens. In terms of developmental biology, they can roughly be divided into two groups. In humans and in mice, all organs and tissues have resident long-lasting macrophages that are already formed during in the fetal liver and perform specific functions in the different types of tissue. The embryonic macrophages in the lungs are involved in the vital oxygen-carbon exchange that takes place in the alveoli.

The second group of macrophages emerge during blood formation in the bone marrow and migrate through the bloodstream into different tissues, where they then mature into tissue-specific macrophages.

"Until now, it was thought that bone marrow-derived macrophages had the same function as alveolar macrophages originating in the fetal liver, and that this was true for all tissues," explains Federica Piattini and Fengqi Li, who are part of Kopf's research group and both first authors of the paper. They have now refuted this hypothesis, showing that, in fact, bone marrow-derived macrophages cause damage in cases of viral pulmonary infection.

The two researchers created two groups of mice: one group had alveolar macrophages originating during the embryonic stage, and the other group had bone marrow-derived macrophages. When they were infected with the , the mice with the bone marrow-derived alveolar macrophages became much sicker and died. One reason for the severe disease progression was that these macrophages caused a strong inflammatory reaction (cytokine storm).

The authors of the study conclude that the origin of macrophages plays a critical role in the progression of the disease. And they showed that influenza infections in mice stimulate the replacement of alveolar macrophages.

Evidence of similar processes with COVID-19

According to the researchers, it makes sense and is valid to compare their influenza experiments on mice with coronavirus infections in humans. "It appears that similar processes occur in the case of COVID-19," says Kopf. One earlier study reported that the embryonic pulmonary macrophages are largely preserved in COVID-19 patients with a mild disease progression, whereas severe disease progression is linked to inflammatory alveolar macrophages originating in the bone marrow.

However, it appeared that the embryonic alveolar macrophages were not replaced exclusively in cases of severe viral infection. Kopf's group showed that this replacement also occurs in aging mice, even if they had never been previously infected. The transplantation of alveolar macrophages from old to young mice resulted a severe flu progression ending in death.

It is known that there is a much greater risk of severe influenza or COVID-19 infection in . "There are certainly several reasons for this," says Kopf. The new data, however, suggests that the loss of embryonic macrophages over the course of life plays a role here.

The ETH professor and his team now plan to study the of dying embryonic .

More information: Fengqi Li et al, Monocyte-derived alveolar macrophages autonomously determine severe outcome of respiratory viral infection, Science Immunology (2022). DOI: 10.1126/sciimmunol.abj5761

Journal information: Science Immunology
Provided by ETH Zurich
Citation: Severe flu risk as immune cells swap with age (2022, July 8) retrieved 29 February 2024 from
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Explore further

Why are some COVID-19 infected people asymptomatic?


Feedback to editors